Erratum (DOI:10.1016/j.cancergencyto.2006.09.006);A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip device

Cancer Genetics and Cytogenetics

Volumn 173, Issue 1, 2007, Pages 17-22

  Harrison, Christine J ^a   Griffiths, Mike ^b   Moorman, Fìona ^a   Schnittger, Susanne ^c   Cayuela, Jean Michel ^d   Shurtleff, Sheila ^e   Gottardi, Enrico ^f   Mitterbauer, Gerlinde ^g   Colomer, Dolores ^h   Delabesse, Eric ⁱ   Castéras, Vincent ^j  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d SAINT LOUIS HOSPITAL   (France)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f SAN LUIGI GONZAGA HOSPITAL   (Italy)

^g UNIVERSITY OF VIENNA   (Austria)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ Laboratoire Central d'Hematologie   (France)

^j IPSOGEN   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE LEUKEMIA; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE TRANSLOCATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

ALIAS;

EID: 33846652459     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.10.001     Document Type: Erratum

References (26)

1. Harrison C.J. The management of patients with leukaemia: the role of cytogenetics in this molecular era. Br J Haematol 108 (2000) 19-30
2. Secker-Walker L.M., and European 11q23 Workshop Participants. General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997. Leukemia 12 (1998) 776-778
3. Pui C.H., Gaynon P.S., Boyett J.M., Chessells J.M., Baruchel A., Kamps W., Silverman L.B., Biondi A., Harms D.O., Vilmer E., Schrappe M., and Camitta B. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359 (2002) 1909-1915
4. Hayette S., Tigaud I., Maguer-Satta V., Bartholin L., Thomas X., Charrin C., Gadoux M., Magaud J.P., and Rimokh R. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood 99 (2002) 4647-4649
5. Biondi A., Cimino G., Pieters R., and Pui C.H. Biological and therapeutic aspects of infant leukemia. Blood 96 (2000) 24-33
6. Bloomfield C.D., Archer K.J., Mrozek K., Lillington D.M., Kaneko Y., Head D.R., Dal Cin P., and Raimondi S.C. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33 (2002) 362-378
7. Dimartino J.F., and Cleary M.L. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 106 (1999) 614-626
8. Bernard O.A., and Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 13 (1995) 75-85
9. Huret J.L., Dessen P., and Bernheim A. An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners. Leukemia 15 (2001) 987-989
10. Swansbury G.J., Slater R., Bain B.J., Moorman A.V., Secker-Walker L.M., and European 11q23 Workshop participants. Hematological malignancies with t(9;11)(p21-22;q23): a laboratory and clinical study of 125 cases. Leukemia 12 (1998) 792-800
11. Johansson B., Moorman A.V., Haas O.A., Watmore A.E., Cheung K.L., Swanton S., Secker-Walker L.M., and European 11q23 Workshop participants. Hematologic malignancies with t(4;11)(q21;q23): a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia 12 (1998) 779-787
12. Moorman A.V., Hagemeijer A., Charrin C., Rieder H., Secker-Walker L.M., and European 11q23 Workshop participants. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. Leukemia 12 (1998) 805-810
13. Armstrong S.A., Staunton J.E., Silverman L.B., Pieters R., den Boer M.L., Minden M.D., Sallan S.E., Lander E.S., Golub T.R., and Korsmeyer S.J. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30 (2002) 41-47
14. Pui C.H., Behm F.G., Downing J.R., Hancock M.L., Shurtleff S.A., Ribeiro R.C., Head D.R., Mahmoud H.H., Sandlund J.T., and Furman W.L. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 12 (1994) 909-915
15. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A., and Medical Research Council Adult and Children's Leukaemia Working Parties. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML10 trial. Blood 92 (1998) 2322-2333
16. Rubnitz J.E., Raimondi S.C., Tong X., Srivastava D.K., Razzouk B.I., Shurtleff S.A., Downing J.R., Pui C.H., Ribeiro R.C., and Behm F.G. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 20 (2002) 2302-2309
17. Martinez-Climent J.A., Espinosa III R., Thirman M.J., le Beau M., and Rowley J.D. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias: identification of the t(9;11) as an indicator of long survival. J Pediatr Hematol Oncol 17 (1995) 277-283
18. Ayton P.M., and Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20 (2001) 5695-07
19. Harrison C.J., Moorman A.V., Barber K.E., Broadfield Z.J., Cheung K.L., Harris R.L., Jalali G.R., Robinson H.M., Strefford J.C., Stewart A., Wright S., Griffiths M., Ross F.M., Harewood L., and Martineau M. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 129 (2005) 520-530
20. Cuthbert G., Thompson K., Breese G., McCullough S., and Bown N. Sensitivity of FISH in detection of MLL gene rearrangements. Genes Chromosomes Cancer 29 (2000) 180-185
21. Pallisgaard N., Hokland P., Riishoj D.C., Pedersen B., and Jorgensen P. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 92 (1998) 574-588
22. Maroc N., Morel A., Beillard E., De La Chapelle A.L., Fund X., Mozziconacci M.J., Dupont M., Cayuela J.M., Gabert J., Koki A., Fert V., and Hermitte F. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia 18 (2004) 1522-1530
23. Gabert J., Beillard E., van der Velden V.H., Bi W., Grimwade D., Pallisgaard N., Barbany G., Cazzaniga G., Cayuela J.M., Cave H., Pane F., Aerts J.L., De Micheli D., Thirion X., Pradel V., Gonzalez M., Viehmann S., Malec M., Saglio G., and van Dongen J.J. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukemia 17 (2003) 2318-2357
24. Caldas C., So C.W., MacGregor A., Ford A.M., McDonald B., Chan L.C., and Wiedemann L.M. Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene. Gene 208 (1998) 167-176
25. Nam D.K., Honoki K., Yu M., and Yunis J.J. Alternative RNA splicing of the MLL gene in normal and malignant cells. Gene 178 (1996) 169-175
26. Rabbitts T.H., and Stocks M.R. Chromosomal translocation products engender new intracellular therapeutic technologies. [Commentary]. Nat Med 9 (2003) 383-386